Let's Know! Intervention for Childhood Language Disorders
(LK!2 Trial)
Trial Summary
What is the purpose of this trial?
In the proposed project, the investigators will conduct a multisite randomized controlled trial (RCT) to determine the efficacy of Let's Know!2, a small-group, language focused comprehension intervention, on children's lower- and higher-level language skills and comprehension skills in the short- and long-term (Specific Aims 1 and 2). The investigators will also explore whether intervention effects are moderated by dosage, initial language skill, developmental language disorder (DLD) status, word reading skill, nonverbal IQ, and family socioeconomic status (Specific Aim 3). Children who have low language skills and are thus at risk for reading comprehension difficulties will participate in the study. Children will be randomly assigned to receive Let's Know! in small groups at their respective schools or to a business-as-usual control condition. The investigators will measure children's language and comprehension skills at the beginning and end of Grade 1 as well as in Grade 2 and Grade 3. The investigators hypothesize that children who experience Let's Know! will end Grade 1 with higher language skills than children in the control condition and that this will translate into better listening and reading comprehension skills as these children matriculate through elementary school.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the Let's Know! treatment for childhood language disorders?
How is the Let's Know! treatment for childhood language disorders different from other treatments?
The Let's Know! treatment is unique because it involves a small-group intervention, which may offer more personalized attention compared to traditional large-group or individual therapies. This approach can enhance social interaction and communication skills among children with language disorders.15678
Research Team
Tiffany P Hogan, PhD
Principal Investigator
MGH Institute of Health Professions
Eligibility Criteria
This trial is for Grade 1 children with low language skills, at risk of comprehension difficulties. They must have parental consent, score below a specific language screener threshold, and possess basic English proficiency. Children with profound disabilities or serious behavior issues affecting classroom participation are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pretest Assessment
Pretest assessments to measure language skills and other abilities before intervention
Treatment
Participants receive the Let's Know! intervention in small groups, focusing on language skills
Posttest Assessment
Posttest assessments to measure changes in language and comprehension skills
Follow-up
Participants are monitored for long-term effects on language and comprehension skills
Treatment Details
Interventions
- Let's Know! small-group or TierL 2 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
MGH Institute of Health Professions
Lead Sponsor
University of Kansas
Collaborator
Ohio State University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator